Radiation Therapy vs. Surgery for Prostate Cancer: What the Decision Really Involves

Understanding the Two Primary Treatment Paths

When prostate cancer is diagnosed and confined to the prostate gland — what clinicians call localised disease — two treatment approaches dominate discussions: radical prostatectomy (surgical removal of the prostate) and radiation therapy (using high-energy beams or implanted seeds to destroy cancer cells). Both have decades of clinical evidence supporting their effectiveness in controlling localised disease.

It's worth noting that a third path, active surveillance, exists for low-risk cancers and involves monitoring rather than immediate treatment. For a thorough comparison of that option, see active surveillance vs. immediate treatment. This article focuses specifically on the surgery-versus-radiation decision for men who have decided to pursue active treatment.

Radiation itself comes in several forms. External beam radiation therapy (EBRT) delivers focused radiation from outside the body over several weeks. Brachytherapy involves implanting small radioactive seeds directly into the prostate. Many radiation plans combine both. Your oncology team will recommend a form based on tumour characteristics and overall health.

Side Effects: What the Research Actually Shows

Side effects are frequently the deciding factor for men choosing between these treatments — and the profiles genuinely differ.

Urinary Function

Surgery carries a higher short-term risk of urinary incontinence (leakage), which typically improves over months but may persist in a minority of men. Radiation is more commonly associated with urinary irritation — increased urgency, frequency, or mild burning — during and shortly after treatment. A small but real risk of longer-term urinary stricture (narrowing) exists with both approaches.

Sexual Function

Erectile dysfunction is a recognised risk of both treatments. With surgery, nerve-sparing techniques can help preserve erectile function, though outcomes vary considerably based on age and pre-treatment baseline. Radiation-related erectile changes tend to develop more gradually over months to years. Neither approach guarantees preservation of function.

Bowel Function

Radiation carries a greater risk of bowel side effects — rectal irritation, urgency, or bleeding — particularly with older techniques. Modern precision delivery methods have substantially reduced this risk. Surgery does not carry the same bowel risk profile.

Men with significant pre-existing urinary symptoms, prior pelvic surgery, or inflammatory bowel conditions may face different risk profiles under each approach. This makes individual assessment with your care team especially important.

Recovery, Logistics, and Practical Considerations

The practical realities of each treatment differ considerably and matter for quality of life.

Surgery typically involves a hospital stay of one to two days, a catheter for one to two weeks post-operatively, and a return to light activity within four to six weeks. Most men are fully recovered within two to three months, though recovery varies by age and general fitness.

Radiation therapy is generally outpatient. External beam schedules have become shorter with modern hypofractionation protocols — some men complete treatment in as few as five sessions, though schedules vary. Brachytherapy may require a brief hospital stay for seed implantation. Daily life is typically less disrupted during treatment, but the treatment period itself extends over weeks.

For context on how hormonal treatments sometimes used alongside radiation differ from other hormonal interventions, our overview of testosterone and hormonal therapies provides useful background. A broader look at the full landscape of prostate health is available in our complete prostate health overview.

This article is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding your specific diagnosis, treatment options, and circumstances.